Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-50
Closed -$3.78K 1154
2026
Q1
$3.78K Sell
50
-258
-84% -$19.4K ﹤0.01% 912
2025
Q4
$22.9K Sell
308
-2,300
-88% -$168K ﹤0.01% 667
2025
Q3
$176K Sell
2,608
-25
-0.9% -$1.66K 0.02% 333
2025
Q2
$172K Hold
2,633
0.03% 336
2025
Q1
$163K Sell
2,633
-44
-2% -$2.92K 0.03% 333
2024
Q4
$193K Buy
2,677
+40
+2% +$3.13K 0.03% 313
2024
Q3
$215K Buy
2,637
+4
+0.2% +$320 0.03% 293
2024
Q2
$196K Buy
2,633
+500
+23% +$37.5K 0.03% 276
2024
Q1
$166K Sell
2,133
-100
-4% -$7.44K 0.03% 311
2023
Q4
$160K Hold
2,233
0.03% 302
2023
Q3
$155K Buy
2,233
+50
+2% +$3.78K 0.04% 274
2023
Q2
$177K Buy
2,183
+383
+21% +$31.3K 0.04% 244
2023
Q1
$145K Hold
1,800
0.04% 276
2022
Q4
$135K Buy
+1,800
New +$128K 0.04% 266

Other funds holding HOLX

Colonial Trust's HOLX Position: Q2 2026 in Review

Colonial Trust sold out of Hologic (HOLX) in Q2 2026, closing a stake of 50 shares — an estimated $3.78K sold.

Colonial Trust first reported a position in HOLX in Q4 2022 and held it in 14 quarters. The position peaked at $215K in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Colonial Trust reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Colonial Trust sold 50 Hologic shares in Q2 2026, an estimated $3.78K.
  • Colonial Trust first reported a position in Hologic in Q4 2022 and held it in 14 quarters.
  • Colonial Trust's Hologic position peaked at $215K in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.